Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$507K Buy
3,460
+128
+4% +$23.2K 0.05% 275
2026
Q1
$490K Buy
3,332
+24
+0.7% +$3.9K 0.06% 271
2025
Q4
$645K Sell
3,308
-193
-6% -$46K 0.07% 229
2025
Q3
$985K Sell
3,501
-968
-22% -$247K 0.12% 168
2025
Q2
$977K Sell
4,469
-190
-4% -$30.7K 0.12% 148
2025
Q1
$651K Buy
4,659
+1,720
+59% +$280K 0.09% 195
2024
Q4
$490K Buy
+2,939
New +$522K 0.07% 231

Other funds holding ORCL

Novem Group's ORCL Position: Q2 2026 in Review

Novem Group increased its Oracle (ORCL) stake by 3.8% in Q2 2026, buying an estimated $23.2K and bringing the position to 3,460 shares worth $507K. The position accounts for 0.05% of the portfolio, ranked #275.

Novem Group first reported a position in ORCL in Q4 2024 and has held it in 7 quarters since. The position peaked at $985K in Q3 2025. 1,688 funds tracked by Wall St. Rank hold ORCL as of Q2 2026.

  • Novem Group held 3,460 shares of Oracle worth $507K as of Q2 2026.
  • Novem Group bought 128 Oracle shares in Q2 2026, an estimated $23.2K.
  • Oracle made up 0.05% of Novem Group's portfolio in Q2 2026, its #275 holding.
  • Novem Group first reported a position in Oracle in Q4 2024 and has held it in 7 quarters since.
  • Novem Group's Oracle position peaked at $985K in Q3 2025.
  • 1,688 funds tracked by Wall St. Rank held Oracle as of Q2 2026.

Based on Novem Group's 13F filing for Q2 2026, filed 21 Jul 2026.